SUMMARY The effect of practolol, D600, and alterations in ionized magnesium concentration on the cardiovascular pharmacology of calcium was examined in vivo in the open-chest dog. In the presence of practolol the ionized calcium-dP/dt (first derivative of left ventricular pressure) concentration-response curve was shifted to the right, with a decreased slope and maximum. Practolol also shifted ionized calcium-S a T, (S wave to peak of T wave on ECG) relationships to the right but in a parallel fashion. Compound D600 produced a parallel shift to the right of ionized calcium-dP/dt relationships but only at maximal doses (0.80 mg/kg). In the presence of practolol, 2.5 mg/kg, D600 shifted ionized calcium-dP/dt relationships to the right at doses (0.8 and 0.25 mg/kg) that had no effect in the absence of practolol. Ionized calcium-dP/dt relationships were the same before and after chelation with EGTA, in contrast to results of the same experiment performed with sodium citrate as the complexing agent. In the intact canine heart, practolol appears to act as a noncompetitive antagonist, D600 as a competitive antagonist, and ionized magnesium as an antagonist of the effects of ionized calcium on dP/dt. D600 in doses of 0.25 mg/kg and 0.80 mg/kg produced hyperglycemia, and this effect was prevented by prior administration of practolol.
IN A PREVIOUS study 1 we described a method for determining precise in vivo concentration-response relationships between ionized calcium (Ca 2+ ) and the mechanical and electrical activity of the heart. With this method Ca 2+ raised or lowered by infusions of calcium gluconate or sodium citrate and then directly measured by an ionspecific electrode. 2 -3 With this technique Ca 2+ -dP/dt (first derivative of the left ventricular pressure rise) relationships are precise and reliable between 2 and 10 mg/100 ml, and four curves from measurements repeated over a 272-hour interval are superimposable.
In our present study we have used this method to define pharmacological relationships between Ca 2+ and members of three classes of agents that are thought to alter the effects of Ca 2+ on the heart: alterations in the level of ionized magnesium (Mg 2+ ), /3-adrenergic blockade with practolol, and "calcium antagonism" with compound D600.
Methods
Thirty mongrel dogs weighing between 14 and 25 kg were used in this study. Materials and methods were identical to those previously described. 1 Briefly, concentration-response curves between Ca 2+ and dP/dt or S a T c (ECG measurement from S wave to peak of T wave -=-VR~R interval) were performed by infusing calcium gluconate after first producing hypocalcemia to the point of circulatory depression with an infusion of sodium citrate. Twenty-seven dogs were paced with an electrode sutured to the left ventricular epicardium near the apex, and three were studied at a spontaneous rate. Practolol was prepared before each experiment by dissolving it in 5.0 ml of 0.1 N Hcl and then adding 5.0 ml of 0.1 N NaOH to give 10 ml of a solution of 10 mg/ml. Compound D600 (methoxyverapamil) was prepared by dissolving it in 0.9% NaCl to give a final concentration of 2 mg/ml. Ethyleneglycolbis (/3-aminoethyl ether)-N,/v"-tetraacetic acid (EGTA) was prepared as a 10% solution in water and passed through a 0.45-/xm Millipore filter. Practolol was administered iv over 5-10 minutes; the infusion of practolol was completed 15 minutes prior to the determination of a Ca 2+ concentration-response curve. If repeat Ca 2+ curves were determined in the presence of practolol, the drug was administered at a rate of 0.5 mg/kg per hour following the initial dose. D600 was given slowly iv over 5-30 minutes at a rate not exceeding 0.1 mg/kg per min. EGTA was infused with a Harvard pump at a rate of 4.0-8.0 mg/kg per min. Sodium citrate as a 15% solution was prepared and administered as previously described.
experiments. The mean value was slightly higher (8-10 mm Hg) at the midpoint (EC50) of concentration-response curves in paced dogs than in nonpaced (6-8 mm Hg at EQo). Left atrial pressures or left ventricular end diastolic pressures were 2-3 mm Hg higher at the EC 50 in the presence of practolol and D600. A temporary reduction in mean arterial pressure of more than 10 mm Hg from the control value was compensated for by an adjustment of a screw clamp placed around the descending aorta distal to the subclavian artery. When a persistent reduction in mean arterial pressure was encountered, such as after administration of D600 and practolol, dP/dt was calculated from a common developed left ventricular pressure below the level of opening of the aortic valve (CPIP). In most cases this was derived from an automatic cutoff on the dP/dt circuit that was capable of eliminating all signals above a predetermined level on the left ventricular pressure rise, e.g., dP/dt40 or dP/dt 65.
Ionized calcium was measured in sera with the AMT Electrion System, model auto I (Applied Medical Tech- 
Results

EFFECT OF PRACTOLOL ON IONIZED CALCIUM-dP/dt RELATIONSHIPS (Ca
2+ -dP/dt)
The effect of practolol on the Ca 2+ -induced increase in peak dP/dt in a paced preparation is shown in Figure 1A . An initial curve was determined in the absence of practolol and followed by two curves in the presence of increasing doses of the /3-blocking agent. Figure 2A illustrates mean Ca 2+ -dP/dt curves for five dogs in the absence and presence of practolol 2.5 mg/kg. Further increases in the practolol dose had little effect on Ca 2+ -dP/dt. Full concentration-response relationships could not be determined in spontaneously beating preparations because of the development of atrioventricular conduction delays at high Ca 2+ levels. Practolol produced a progressive shift to the right in Ca 2+ -dP/dt relationships, with a decrease in the slope and a reduction in the maximum of the concentration-response curve.
EFFECT OF PRACTOLOL ON IONIZED CALCIUM-S a T c RELATIONSHIPS (Ca
2+
-S a T c ) Figure IB shows the log Ca 2+ -S a T c data for the experiment presented in Figure 1A , and Figure 2B shows the plot of the mean S T c results corresponding to data presented in Figure 2A . Practolol produced a parallel shift to the right in Ca 2+ -S a T c concentration-response curves, in contrast to its effect on Ca 2+ -dP/dt relationships.
IONIZED CALCIUM-dP/dt RELATIONSHIPS IN CURVES REPEATED IN THE PRESENCE OF PRACTOLOL
Although practolol reduced the maximum dP/dt obtainable with Ca 2+ the changes produced by Ca 2+ were of such a magnitude that reliable measurements could be made and repeat curves could be performed. The dose of practolol was 2.5 mg/kg given initially and followed by 0.5 mg/kg per hour. Figure 3A presents mean Ca 2+ -dP/dt values in four dogs which were studied with curves repeated in the presence of practolol. In contrast to Ca 2+ curves performed in the absence of /3-blocakde 1 the dP/dt relationships showed a progressive left shift as each curve was performed. This shift to the left was not prevented by increasing the practolol "maintenance" dose to 1 mg/kg per hour. Ionized magnesium levels (Mg Figure 3B presents Ca 2+ -S a T c relationships from the same preparations presented in Figure 4A . In contrast to Ca 2+ -dP/dt curves, the four repeat Ca 2+ -S T c curves are entirely superimposable. 
FIGURE 4 Effect of ionized calcium in dP/dt relationships before and after exposure to (A) 15% sodium citrate and (B) 10%
EGTA.
• could account for such differences in Ca 2+ -dP/dt relationships. Figure 4A shows the results of three experiments in /3-blocked preparations in which Ca 2+ was infused before and after exposure to citrate. Calcium gluconate was infused initially and then followed by a citrate infusion to produce hypocalcemia, after which the calcium infusion was repeated. Ca 2+ -dP/dt and Ca 2+ -S a T c relationships were determined during each calcium infusion as well as during the citrate infusion. This experiment is similar to that previously reported 1 except that the three curves were obtained in the presence of practolol, 2.5 mg/kg initially, followed by 0.5 mg/kg per hour.
In contrast to the equal dissociation constants (K A ) of calcium and magnesium citrate, the K A of calcium-EGTA is 10" 5 times that of magnesium-EGTA; EGTA therefore has a 100,000 fold greater affinity for complexing with . Figure 4B shows the Ca 2+ -dP/dt relationships of five experiments performed in /3-blocked preparations in which calcium was initially infused, EGTA rather than citrate was then infused to lower the Ca 2+ , and calcium gluconate was reinfused. Unlike Ca 2+ -dP/dt relationships obtained before and after citrate infusions the calcium curves before and after EGTA are nearly superimposable.
Because of circulatory depression more than two Ca 2+ curves could not be determined after exposure to EGTA. Two dogs in which four repeat curves were attempted died in irreversible cardiovascular collapse following the third EGTA infusion, indicating toxicity of the EGTA or EGTA-Ca complex.
EFFECTS OF D600 IN SPONTANEOUSLY BEATING PREPARATIONS
The effects of variations in plasma Ca 2+ were studied in three nonpaced preparations in the presence and absence of the organic calcium antagonist compound D600. 5 A representative experiment is shown in Figure 5 . The most striking effect of D600 on electrical and hemodynamic parameters in the presence of increasing Ca 2+ concentrations is a prolongation of the P-R interval and a decrease in heart rate. These effects plus a slight reduction in mean arterial pressure are seen at a dose of 0.25 mg/kg with 0.025 mg/kg having little or no effect. Ca 2+ -dP/dt relationships are qualitatively similar before and after D600, considering the reduced heart rate, and the same maximum is reached. A dose of 0.08 mg/kg of D600 produced results intermediate between 0.025 and 0.25 mg/kg. Similar results were obtained in two other preparations studied in this manner.
EFFECT OF D600 ON Ca' + -dP/dt RELATIONSHIPS IN PACED PREPARATIONS
Because of the decrease in heart rate and conduction delays produced by D600 it was necessary to derive quantitative effects of D600 on the Ca 2+ concentration-response curve from dogs which were paced from the left ventricle. VOL. 41, No. 4, October 1977 Four dogs were studied with doses of D600 ranging from 0.025 to 0.80 mg/kg. Four complete Ca 2+ curves were determined for each dog, the first in the absence of D600 and the subsequent three in the presence of cumulative doses of the drug that were increased by 0.5 log unit (0.025, 0.08, 0.25, and 0.80 mg/kg) per curve. Figure 6A shows the effects of D600 on the Ca 2+ -peak dP/dt relationships in an individual experiment. Peak dP/dt rather than a dP/dt at a commonly developed isovolumetric intraventricular pressure was used because the mean arterial pressure varied by less than 10 mm Hg per curve (X = 94 ± 3.2, 91 ± 4.1, 95 ± 3.6, and 90 ± 4.0 in curves 1 through 4, respectively.) Note that there is a very small shift to the right at 0.25 mg/kg and a much larger shift at 0.80 mg/kg. The repeat curves are parallel and the same maximum is reached in the presence of D600 as in its absence. Figure 6B shows data for another preparation in which the D600 concentration was 0.025, 0.08, and 0.25 mg/kg. There is no effect of D600 on Ca 2+ -peak dP/dt concentration-response relationships. Figure 7A gives the mean Ca 2+ -peak dP/dt or dP/dt 65 curves normalized to 100% = maximum response for the four dogs studied with doses of D600 of 0.25 mg/kg and 0.80 mg/kg. There is a small parallel shift to the right at 0.25 mg/kg and a larger parallel shift at 0.80 mg/kg. Doses greater than 0.80 mg/ kg resulted in irreversible cardiovascular collapse and could not be evaluated. Figure 7B shows the mean S a T c values from the preparations presented in Figure 7A . During the first portion of the curve D600 has no effect on the S a T c at doses which cause parallel shifts to the right in Ca 2+ -dP/dt concentration-response relationships. Several preparations were noted to have a decreased maximum for the degree of shortening of the S a T c in the presence of D600 in spite of no change in relationships up to the EC 50 . This is reflected in the shape of the upper part of the mean curves shown in Figure 7B .
FIGURE 8 Effect ofD600 on ionized calcium-dP/dt (A) and S a T c (B) relationships in B-blocked (2.5 mg/kg practolol) preparations, mean of six experiments. (A)
EFFECT OF D600 ON Ca 2+ dP/dt RELATIONSHIPS IN B-
BLOCKED PREPARATIONS
Six dogs received practolol, 2.5 mg/kg, followed by 0.5 mg/kg per hour, and had Ca 2+ -dP/dt relationships determined in the absence and presence of increasing cumulative doses of D600. Results are normalized to 100% = maximum dP/dt obtained on each curve as previously described.
1 Figure 8A shows the effects of progressive increases of D600 on Ca 2+ -dP/dt relationships in these preparations. A cumulative dose of D600 of 0.25 mg/kg produced cardiovascular collapse in three of six dogs despite the fact that the drug was given very slowly (over a 30-minute time period) and in the presence of hypercalcemia. A dose of 0.08 mg/kg of D600 produced a shift of the Ca 2+ -dP/dt curve to the right, in contrast to results for preparations which were not /3-blocked, in which this dose had no effect. D600 at 0.08 and 0.25 mg/kg produced parallel shifts of the Ca
2+
-dP/dt concentration-response curves to the right. Figure 8B shows the Ca 2+ -S a T c relationships for the dogs shown in Figure 8A . Only the dose of D600 at 0.25 mg/kg is shown, as 0.08 mg/kg had variable effects on the Ca 2+ -S T c curves up to the EC 50 level. In contrast to Ca 2+ -S a T c relationships in the presence of D600 without practo-v lol, the addition of /3-blockade causes D600 to shift the S a T c curve to the right. Figure 9 contains data from an individual experiment showing the effect on Ca 2+ -S a T c relationships of adding first practolol then D600 at 0.08 and 0.25 mg/kg. D600 can produce an additive, parallel shift to the right of the Ca 2+ -S a T c curve that has previously been shifted by practolol.
EFFECT OF D600 ON Ca^-SaT,. IN /3-BLOCKED PREPARATIONS
LETHAL CONCENTRATIONS OF IONIZED CALCIUM IN DOGS RECEIVING PRACTOLOL, D600, AND PRACTOLOL PLUS D600
The mean lethal concentration of ionized calcium in the various groups of dogs studied is given in Table 1 , along with the values from paced controls in a previous study. 1 There is no difference in the lethal level of ionized calcium between any of the four groups studied; the difference between the control and practolol-treated dogs is not statistically significant (P > 0.1).
EFFECT OF D600 ON BLOOD GLUCOSE LEVELS
Blood glucose levels at the EC 0 , EC 50 , and EC 10 o of each Ca 2+ curve were measured in dogs treated with practolol, D600, and practolol plus D600. Dogs treated with D600, Paced control (n = 9) + practolol (n = 6) + D600 (n = 7) D600 + practolol (n = 6) 0.80 mg/kg, had a statistically significant elevation in blood glucose as compared to matched controls taken from the initial concentration-response curve in the absence of D600: EC 0 , 213 ± 22 mg/100 ml vs. 131 ± 16; EC 50 , 201± 19 vs. 138 ± 23; EC i00 , 212 ± 15 vs. 140 ± 10; all P values < 0.05. The dose of D600 at 0.25 mg/kg resulted in a small but statistically significant (P < 0.05) increase in glucose at the EQoo but the dose at 0.08 mg/kg had no effect.
In contrast to D600, practolol decreased the blood glucose. The mean values at the EQ>, EC 50 , and ECioo levels are less (P < 0.05) than comparable measurements presented in a previous publication 1 for curves performed in the absence of practolol. Also, the presence of practolol inhibits the increase in glucose associated with 0.25 mg/kg D600.
Discussion
This study uses the citrate-ionized calcium model to further investigate quantitative pharmacological relationships of Ca 2+ in vivo. In a previous study, 1 we found that this model was extremely stable through four concentration-response curves performed over a 2'/2-hour period, and that both dP/dt and the ECG interval S T t . were quantitatively related to log Ca z+ . Because of the ability of this in vivo model to resemble an isolated tissue preparation in terms of stability and reliability, we elected to examine in detail the effect of several pharmacological agents that are thought to affect Ca 2+ and the contractile state of the heart.
The first series of experiments was designed to assess the effect of /3-adrenergic blocking agents on Ca 2+ -dP/dt and Ca 2+ -S a T c relationships. We chose practolol because it is a "selective" /3-blocking agent which is more potent in the heart than in other tissues 6 -7 and because it possesses relatively little of the local anesthetic and direct myocardial depressant effects common in other /3-antagonists. 6 An inhibition of the Ca 2+ -force relationship in vitro by propranolol had been previously described 8 but was not quantitated.
Practolol produced a dose-related shift to the right of the Ca 2+ -dP/dt concentration-response curve accompanied by a decrease in the slope and maximum. This effect probably relates to differences in characteristics of the preparation at high and low levels of adrenergic activity rather than to effects on drug-receptor interactions. The effect is of such magnitude as to make Ca 2+ a very poor inotropic agent in the absence of /3-adrenergic activity. Practolol also shifted the Ca 2+ -S a T c concentration curve to the right, but in a parallel fashion. D600 produced slight parallel shifts to the right of Ca 2+ -VOL. 41, No. 4, OCTOBER 1977 dP/dt relationships and only at relatively high doses (0.25 and 0.80 mg/kg) that were accompanied by significant effects on P-R interval and heart rate in dogs in sinus rhythm. These same doses of D600 had no apparent effect on the Ca 2+ -S a T c relationship. The effects of D600 on dP/ dt were much more pronounced in experiments in which /3-adrenergic blockade was present. In these preparations, a dose of D600 (0.08 mg/kg) that had no effect on dP/dt in non-/3-blocked preparations antagonized Ca 2+ , and the dose of D600 at 0.25 mg/kg produced a much greater shift. A dose of 0.8 mg/kg of D600 was tolerated in non-/3-blocked preparations but could not be administered to dogs that had received practolol; in these dogs 0.25 mg/kg was the LD 50 . Also, in the presence of practolol, D600 shifted the S a T c concentration-response curve to the right at a dose of D600 (0.25 mg/kg) that had no effect in the absence of /3-blockade.
It would seem, then, that D600 is able to pharmacologically antagonize Ca 2+ in vivo, but the degree of antagonism and tolerance of the negative inotropic effects of the drug are dependent on the level of /3-adrenergic activity. This experimental evidence is in keeping with the clinical observation that simultaneous administration of a /3-blocking agent and a calcium antagonist can result in marked myocardial depression. 9 These findings suggest that the action of calcium antagonists and /3-blocking agents is related but that they act by different mechanisms. Previous work describing the effects of catecholamines on the restoration of slow inward current 10 and the effects of agents that elevate cyclic AMP on restoration of slow inward current and tension development" support this notion.
Since the fraction of Ca 2+ responsible for modulating the contractile state is in rapid equilibrium with plasma Ca 2+ , 12 ' 13 it is possible to make inferences about the nature of drug-receptor interactions from the shape of the concentration-response curve. The parallel rightward shift of the Ca 2+ -dP/dt curve in the presence of increasing doses of D600 provides presumptive evidence for competitive antagonism of Ca 2+ by D600, implying a specific locus at which both D600 and Ca 2+ interact. This is in agreement with the effect of D600 in isolated rabbit atrial preparations, in which D600 satisfies stringent criteria for competitive antagonism of Ca 2+ .
14 Since Ca
2+
-practolol relationships were "noncompetitive" in nature, no such interaction at a specific site can be inferred.
Variations in the level of Mg 2+ have previously been reported to affect Ca 2+ -force relationships in vitro, but this effect seemed to be species-specific. 15 Changes in Mg 2+ are one possible explanation for alterations in Ca 2+ -dP/dt relationships in curves performed before and after exposure to citrate. The dissociation constant of calcium citrate and magnesium citrate is the same, 10" 3 -
22
. 16 This means that as Ca 2+ is complexed by infusion of citrate, Mg 2+ is equally reduced, and Ca 2+ concentration-response curves generated by alternating citrate and calcium infusions are performed in the presence of a progressive decrease in Mg 2+ . By the time a fourth such curve is determined, the Mg 2+ has been reduced by approximately 40% of its concentration for the first curve.
1 This effect will also be present in curves determined after a citrate infusion compared to relationships generated by infusion of calcium without previous exposure to citrate. The progressive decrease in Mg 2+ is also one possible explanation for the consistently noted left shift in Ca 2+ -dP/dt relationships that occurs in repeat curves determined in the presence of practolol.
When EGTA is used to complex Ca 2+ , little or no Mg 2+ is removed because the dissociation constant for Ca 2+ -EGTA is 100,000-fold smaller than for Mg 2+ -EGTA. 4 Since prior exposure to EGTA did not alter the position of the Ca 2+ -dP/dt concentration-response curve, a reduction in Mg 2+ seems to be the most likely explanation for the results shown in Figures 4A and 5A . Mg 2+ seems to act as a calcium antagonist in vivo and shifts Ca 2+ -dP/dt curves to the left in a parallel fashion when its effective concentration is reduced. D600 at both 0.25 mg/kg and 0.80 mg/kg elevated blood glucose levels. These effects are probably due to inhibition of insulin release by D600, as has been described for verapamil. 17 The reduction in blood glucose in preparations /3-blocked with practolol was probably secondary to an inhibition of the stimulation of glycogenolysis, an effect known to be mediated by /3-receptors in the dog and other species. 18 ' 19 The lack of D600-related hyperglycemia in the presence of practolol could be secondary to an effect of practolol on insulin release mechanisms. However, it is more likely that the inhibition of glycogenolysis by practolol prevented the expression of D600-mediated insulin inhibition as measured by blood glucose levels. The effect of D600 and practolol on blood glucose illustrates that calcium antagonists and /3-blocking agents can interact in systems other than the heart.
The previous observation 1 that the S a T c is related to log Ca 2+ in a manner very similar to dP/dt suggests that the effect of Ca 2+ on the action potential is related to Ca 2+ activation of contraction. This suggestion is further strengthened by the observation in this study that agents that are known (D600) or predicted (practolol) inhibitors of slow inward current alter the Ca 2+ -S a T c relationships, but that pharmacological maneuvers (alteration in Mg 2+ ) that have not been shown to affect slow inward current or the plateau phase of the action potential 20 have no effect on the Ca 2+ -S a T c relationship. However, it must be stressed that calcium-related effects on the plateau phase of the action potential inferred from changes in the S a T c must involve much more than the slow inward current since, by itself, an increase in slow inward current would be expected to prolong, not shorten, the plateau phase of the action potential.
Effects of D600 and practolol on Ca
2+
-dP/dt were much more pronounced than effects on Ca 2+ -S a T c , and marked antagonism of the inotropic effects of Ca 2+ had to occur before an effect on the S a T c could be detected. With D600, no effect on the S a T c could be demonstrated unless the preparation had been previously ^-blocked. Although the most likely explanation for this is the insensitivity of the S a T c as a measurement of effects on the plateau phase of the action potential, the possibility should be raised that the effect of D600 on Ca 2+ -dP/dt relationships is independent of its effect on the action potential.
This study demonstrates that calcium antagonism can be achieved in vivo in a manner similar to that reported in Practolol, D-600, and practolol plus D600 did not protect against hypercalcemic ventricular fibrillation, implying a relationship of this event to extracellular but not intracellular Ca 2+ . Since both practolol and D600 produce conduction delays in the presence of elevated calcium levels, these drugs would not be of use in the clinical setting of hypercalcemic crisis, in which there is an increased risk of ventricular fibrillation. 21 
